U.S. Food and Drug Administration (USFDA) has concluded inspection at Aarti Drugs’ API manufacturing facility located at Tarapur, Maharashtra. On conclusion of the inspection, the company has received 7 inspectional observations in Form 483, where none of the observations are related to Data Integrity. The company will work closely with US FDA in resolving all points.
There is no impact on financial, operation or other activities of the Company pursuant the observations received. USFDA conducted inspection from September 12, 2024 to September 20, 2024.
Aarti Drugs is engaged in the manufacturing of Active Pharmaceutical Ingredients (APIs), Pharma Intermediates, Specialty Chemicals and also produces Formulations with its wholly-owned subsidiary - Pinnacle Life Science.
| Company Name | CMP |
|---|---|
| Sun Pharma. Inds. | 1927.20 |
| Dr. Reddys Labs. | 1227.00 |
| Cipla | 1425.00 |
| Zydus Lifesciences | 1134.55 |
| Lupin | 2494.20 |
| View more.. | |
Start Research-backed Investing ...Now. Subscribe to Sapphire
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: